Australia markets open in 1 hour 37 minutes

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.05+0.09 (+1.51%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 273.61M
Enterprise value 247.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.88
Price/book (mrq)65.02
Enterprise value/revenue 8.23
Enterprise value/EBITDA -8.22

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3195.57%
S&P500 52-week change 323.57%
52-week high 311.00
52-week low 31.87
50-day moving average 36.24
200-day moving average 37.15

Share statistics

Avg vol (3-month) 329.51k
Avg vol (10-day) 312.96k
Shares outstanding 547.11M
Implied shares outstanding 647.42M
Float 827.78M
% held by insiders 10.00%
% held by institutions 119.69%
Shares short (15 Apr 2024) 450.27k
Short ratio (15 Apr 2024) 40.78
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.11%
Shares short (prior month 15 Mar 2024) 448.29k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -109.64%
Operating margin (ttm)3.46%

Management effectiveness

Return on assets (ttm)-19.72%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)36.21M
Revenue per share (ttm)0.98
Quarterly revenue growth (yoy)854.90%
Gross profit (ttm)N/A
EBITDA -23.69M
Net income avi to common (ttm)-39.7M
Diluted EPS (ttm)-1.16
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)75.28M
Total cash per share (mrq)1.6
Total debt (mrq)50.56M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.75
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-12.48M
Levered free cash flow (ttm)-5.27M